An active metabolite of norgestimate
Related Products
Pro-drug Form(s)
16547Norgestimate
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Norelgestromin

Item No. 35243

Technical Information
Formal Name
13-ethyl-17α-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one, oxime
CAS Number
53016-31-2
Synonyms
  • BRN 4202099
  • Levonorgestrel oxime
  • 17-desacetyl Norgestimate
  • RWJ 10553
Molecular Formula
C21H29NO2
Formula Weight
Purity
≥95%
Formulation
A solid
DMF: 11 mg/mlDMSO: 10 mg/mlEthanol: 12 mg/mlPBS (pH 7.2): 0.25 mg/ml
λmax
242 nm
SMILES
CC[C@@]12[C@](CC[C@@]2(O)C#C)([H])[C@]3([H])CCC4=C/C(CC[C@]4([H])[C@@]3([H])CC1)=N/O
InChi Code
InChI=1S/C21H29NO2/c1-3-20-11-9-17-16-8-6-15(22-24)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23-24H,3,5-12H2,1H3/b22-15+/t16-,17+,18+,19-,20-,21-/m0/s1
InChi Key
ISHXLNHNDMZNMC-VTKCIJPMSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Norelgestromin is an active metabolite of the progestin norgestimate (Item No. 16547).1 Norelgestromin is formed from norgestimate via deacetylation in human liver microsomes. It is an agonist of the progesterone receptor and estrogen receptor α (ERα; EC50s = 11.1 and 43.4 nM, respectively) and an antagonist of the glucocorticoid and mineralocorticoid receptors (IC50s = 255 nM and 83.7 nM, respectively).2 Norelgestromin selectively binds to progestin receptors (IC50 = 4.61 nM for rabbit uterine receptors) over androgen receptors (IC50 = 222 nM for rat prostatic receptors) in radioligand binding assays.3 However, norelgestromin (1 nM) activates the androgen receptor in a transactivation assay in MDA-MB-231 breast cancer cells expressing the human receptor.4 Formulations containing norelgestromin in combination with ethynyl estradiol have been used as contraceptives and in the treatment of acne vulgaris in women.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Madden, S., and Back, D.J. Metabolism of norgestimate by human gastrointestinal mucosa and liver microsomes in vitro. J. Steroid Biochem. Mol. Biol. 38(4), 497-503 (1991).

    2. Paris, F., Balaguer, P., Rimbault, F., et alMolecular action of norgestimate: New developments. Gynecol. Endocrinol. 31(6), 487-490 (2015).

    3. Phillips, A., Demarest, K., Hahn, D.W., et alProgestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 41(4), 399-410 (1990).

    4. Prifti, S., Lelle, I., Strowitzki, T., et alInduction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells. Gynecol. Endocrinol. 19(1), 18-21 (2004).